IGHE and chronic rhinosinusitis with nasal polyps: In recent years, biologics targeting type 2 inflammation, including IL-4, IL-5, IL-13, and IgE, have demonstrated efficacy in treating severe cases of CRSwNP that are resistant to glucocorticoids and surgical interventions.